Clinical trial
Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic…
NCT00182741 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00182741 |
|---|---|
| Title | Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer |
| Official title | Phase II Study of DN-101 (High Dose Pulse Calcitriol), Mitoxantrone, Prednisone in Androgen-Independent Prostate Cancer (AIPC) |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, mitoxantrone hydrochloride, prednisone |
| Enrollment | 19 |
| Start date | Sep 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | May 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: